Loading
Journey Medical Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by ROSENWALD LINDSAY A MD, was filed 27 Mar 2024.
Journey Medical Corp: what insiders have been doing
Journey Medical Corp belongs to the Health Care sector. Filings by its managers are published through SEC (Form 4). In the past year (24 October 2025 to 24 October 2026), 7 filings came from 7 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
With 7 filings in twelve months, the company is quieter than the median of 24 filings across the 3,167 companies we follow on the same exchange. Our records for Journey Medical Corp go back to 2022, with 9 purchases and 22 sales on the open market in total. The 10-K for the year ended 31 December 2025 shows 61.9 m USD of revenue and -11.4 m USD of net income.
Over the last twelve months, not one insider purchase of Journey Medical Corp stock was filed. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
83
Thresholds
n/a
Buy Volume
€707,018
9 ops. · all time
Sell Volume
€1M
22 ops. · all time
Who traded when
BuySaleClaude Maraoui7 sales
Joseph Benesch2 sales
Ramsey Alloush1 sale
Since the insiders bought
- +66.0%Entry US$3.68 · Close at T+365 US$6.11
- +66.4%Entry US$3.69 · Close at T+365 US$6.14
- +66.4%Entry US$3.69 · Close at T+365 US$6.14
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Journey Medical Corp Strong Buy (bullish), based on 4 analysts. Average price target: US$13.75.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 22,330 of 26,280 companies
26.6
score / 100
Value18
Quality35
FCF yld-8.4%
Earn yld-7.8%
EV/EBITDA·
ROE-24%
Gross mgn66%
Net mgn-18%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$5.22
Analyst consensus
4 analystsStrong buy
US$13.00Target US$13.75(+163%)US$15.00
Income statement
RevenueUS$61.9M
Gross profitUS$40.9M66% margin
EBITDA-US$3.3M-5% margin
Net income-US$11.4M-9.0% margin
Valuation
P/Book4.5x
Beta1.11
Balance sheet & cash
Market capUS$147.3M
Total debtUS$25.4M
Free Cash Flow-US$12.4M
Debt / Equity80%
Profitability & ownership
ROE-23.8%
ROA-2.1%
% insiders31.8%
% institutions47.9%
Last declaration on 26 June 2026
Declarations83 total
10,000 sharesCommon Stock, $0.0001 par valueSEC:0001104659-26-078282:0
10,000 sharesCommon Stock, $0.0001 par valueSEC:0001104659-26-078266:0
10,000 sharesCommon Stock, $0.0001 par valueSEC:0001104659-26-078279:0
10,000 sharesCommon Stock, $0.0001 par valueSEC:0001104659-26-078286:0
28,907 shares0Common Stock, $0.0001 par valueSEC:0001104659-26-048733:0
46,863 shares0Common Stock, $0.0001 par valueSEC:0001104659-26-048736:0
49,277 shares0Common Stock, $0.0001 par valueSEC:0001104659-26-048731:0
10,877 shares@ US$7.476.3% of flowCommon Stock, $0.0001 par valueSEC:0001104659-25-083217:1
1,250,000 shares@ US$0.0659.8% of flowCommon Stock, $0.0001 par valueSEC:0001104659-25-083217:0
50,000 shares0Common Stock, $0.0001 par valueSEC:0001104659-25-075272:0
20,000 shares0Common Stock, $0.0001 par valueSEC:0001104659-25-075270:0
20,000 shares0Common Stock, $0.0001 par valueSEC:0001104659-25-075260:0
20,000 shares0Common Stock, $0.0001 par valueSEC:0001104659-25-075266:0
20,000 shares0Common Stock, $0.0001 par valueSEC:0001104659-25-075263:0
7,173 shares0Common Stock, $0.0001 par valueSEC:0001104659-25-066237:0
7,173 shares0Common Stock, $0.0001 par valueSEC:0001104659-25-066236:0
7,173 shares0Common Stock, $0.0001 par valueSEC:0001104659-25-066238:0
7,173 shares0Common Stock, $0.0001 par valueSEC:0001104659-25-066240:0
7,173 shares0Common Stock, $0.0001 par valueSEC:0001104659-25-066239:0
46,863 shares0Common Stock, $0.0001 par valueSEC:0001104659-25-061156:0
28,907 shares0Common Stock, $0.0001 par valueSEC:0001104659-25-061155:0
49,277 shares0Common Stock, $0.0001 par valueSEC:0001104659-25-061149:0
2,857 shares@ US$6.84100.0% of flowCommon Stock, $0.0001 par valueSEC:0001104659-25-044606:0
2,409 shares@ US$6.8413.4% of flowCommon Stock, $0.0001 par valueSEC:0001104659-25-044611:0
4,834 shares@ US$6.844.1% of flowCommon Stock, $0.0001 par valueSEC:0001104659-25-044612:0
25 of 83 declarations
About Journey Medical Corp
Journey Medical Corp is a company focused on the development and commercialization of dermatological treatments. It is listed on NASDAQ under the ticker XNAS.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
